NewAmsterdam Pharma Company NV (NASDAQ: NAMS) established initial surge of 1.60% at $16.53, before settling in for the price of $16.27 at the close. Taking a more long-term approach, NAMS posted a 52-week range of $5.63-$26.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -28.76%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -9.53%. This publicly-traded company’s shares outstanding now amounts to $82.47 million, simultaneously with a float of $39.18 million. The organization now has a market capitalization sitting at $1.49 billion. At the time of writing, stock’s 50-day Moving Average stood at $18.30, while the 200-day Moving Average is $17.87.
NewAmsterdam Pharma Company NV (NAMS) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the NewAmsterdam Pharma Company NV industry. NewAmsterdam Pharma Company NV’s current insider ownership accounts for 56.48%, in contrast to 37.50% institutional ownership. According to the most recent insider trade that took place on Aug 20 ’24, this organization’s Chief Executive Officer bought 5,000 shares at the rate of 16.27, making the entire transaction reach 81,350 in total value, affecting insider ownership by 209,784. Preceding that transaction, on Jun 20 ’24, Company’s Chief Executive Officer bought 5,000 for 17.26, making the whole transaction’s value amount to 86,308. This particular insider is now the holder of 204,784 in total.
NewAmsterdam Pharma Company NV (NAMS) Earnings and Revenue Records
NewAmsterdam Pharma Company NV’s EPS decrease for this current 12-month fiscal period is -9.53% and is forecasted to reach -1.73 in the upcoming year.
NewAmsterdam Pharma Company NV (NASDAQ: NAMS) Trading Performance Indicators
Let’s observe the current performance indicators for NewAmsterdam Pharma Company NV (NAMS). It’s Quick Ratio in the last reported quarter now stands at 9.83. The Stock has managed to achieve an average true range (ATR) of 1.02.
Technical Analysis of NewAmsterdam Pharma Company NV (NAMS)
Now, what If we examine the latest scores posted by [NewAmsterdam Pharma Company NV, NAMS]. During the last 5-days, its volume was better the volume of 0.25 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 27.06% While, its Average True Range was 1.02.
Raw Stochastic average of NewAmsterdam Pharma Company NV (NAMS) in the period of the previous 100 days is set at 12.77%, which indicates a major fall in contrast to 38.82% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 54.32% that was higher than 47.67% volatility it exhibited in the past 100-days period.
